Daniele C Aguiar Selected Research

VU0409106

1/2021

Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele C Aguiar Research Topics

Disease

4	Hyperalgesia 01/2022 - 10/2015
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2013
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Panic Disorder (Panic Attack) 01/2019 - 01/2012
2	Pain (Aches) 01/2022 - 10/2015
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Obesity 01/2021 - 01/2018
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 09/2013
2	Seizures (Absence Seizure) 09/2015 - 08/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Shock 01/2022
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Nervous System Diseases (Neurological Disorders) 09/2015
1	Substance-Related Disorders (Drug Abuse) 11/2014
1	Opioid-Related Disorders (Opiate Addiction) 11/2014
1	Psychotic Disorders (Schizoaffective Disorder) 07/2013
1	Catalepsy 01/2013
1	Neurobehavioral Manifestations 01/2013
1	Dyskinesias (Dyskinesia) 01/2013

Drug/Important Bio-Agent (IBA)

5	EndocannabinoidsIBA 01/2022 - 09/2013
4	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2013
3	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2017
3	Aripiprazole (Abilify)FDA Link 01/2022 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
2	anandamide (arachidonylethanolamide)IBA 01/2022 - 08/2015
2	CarbohydratesIBA 01/2020 - 01/2018
2	Cocaine (Cocaine HCl)IBA 09/2015 - 08/2015
2	CannabidiolIBA 09/2015 - 07/2013
1	Capsaicin (Zostrix)FDA Link 01/2022
1	AcidsIBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	VU0409106IBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021
1	OSU 6162IBA 01/2021
1	LeptinIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2015
1	Formaldehyde (Formol)FDA Link 10/2015
1	Glutamic Acid (Glutamate)FDA Link 09/2015
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 08/2015
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 08/2015
1	EnzymesIBA 08/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Therapeutics 01/2016 - 11/2014
1	Tissue Expansion 01/2020
1	Analgesia 10/2015
1	Injections 08/2015